viernes, 1 de abril de 2016

FDA Foodborne Illness Outbreak Investigation

"FDA Foodborne Illness Outbreak Investigation Update."  There is new information available on this topic at the URL below, and for your convenience the update is also provided below.

FDA Investigated Multistate Outbreak of Listeria in Dole Leafy Greens Products Produced in the Dole Facility in Springfield, Ohio

What was the Problem and What was Done About It?  
The U.S. Food and Drug Administration (FDA), the U.S. Centers for Disease Control and Prevention (CDC), and state and local officials investigated a multi-state outbreak of listeriosis. According to CDC, 19 people infected with the outbreak strain of Listeria monocytogeneshave been reported from nine states since July 5, 2015. The number of ill people reported from each state was as follows: Connecticut (1), Indiana (1), Massachusetts (1), Michigan (4), Missouri (2), New Jersey (1), New York (6), Ohio (2), and Pennsylvania (1).
According to CDC, whole genome sequencing (WGS) was performed on clinical isolates from all ill people and showed that the isolates were highly related genetically. Listeria specimens were collected from ill people between July 5, 2015 and January 31, 2016. Ill people ranged in age (in years) from 3 to 83, and a median age of 64. Seventy-four percent of ill people were female. All nineteen (100%) ill people reported being hospitalized, including one person from Michigan who died as a result of listeriosis. One of the illnesses reported was in a pregnant woman. Of 14 ill people who were asked about packaged salad, 13 (93%) reported eating a packaged salad. Nine (100%) of 9 ill people who specified the brand of packaged salad eaten reported various varieties of Dole brand packaged salad.
As part of a routine product sampling program, the Ohio Department of Agriculture collected a Dole brand Field Greens packaged salad from a retail location and isolated Listeria monocytogenes. This packaged salad was produced at the Springfield, Ohio, Dole processing facility. In January 2016, WGS showed that the Listeriamonocytogenes isolate from the packaged salad was closely related genetically to isolates from ill people. This information linked the illnesses to Dole brand packaged salads produced at the Dole processing facility in Springfield, Ohio.
On January 21, 2016, Dole reported to FDA and CDC that it ceased production of all packaged salads at its processing facility in Springfield, Ohio. Additionally, the company reported that it withdrew all packaged salads currently on the market that were produced at this facility.
On January 22, 2016, the Canadian Food Inspection Agency (CFIA) issued a food recall warning disclaimer icon for products made at the Springfield, Ohio plant and reported that recalled salads had also been shipped to five provinces in Canada.
On January 27, 2016, Dole Fresh Vegetables, Inc. announced that it was recalling all packaged salads produced in its Springfield, Ohio, facility.
On January 28, 2016, the FDA completed its analysis and confirmed the presence of Listeria monocytogenes in a packaged salad produced at the Springfield, Ohio, facility.
According to a March 17, 2016 update disclaimer icon from Public Health Agency of Canada (PHAC), “the outbreak investigation coordinating committee has been deactivated and the investigation is coming to a close.”
On March 31, CDC reported that the outbreak appeared to be over.

What Specific Products were Affected?

In January, 2016, Dole Fresh Vegetables, Inc. recalled all packaged salads produced in its Springfield, Ohio, facility. These products have a shelf-life of about 14 days, so it is unlikely that the products are still in stores or consumers’ refrigerators.
These products were sold in bags and clamshell packaging under the following brand names:
  • Dole
  • Fresh Selections
  • Simple Truth
  • Marketside
  • The Little Salad Bar
  • President's Choice Organics
Recalled products from the Dole processing facility in Springfield, Ohio, had a product code beginning with the letter “A” on the packaging.
Dole Fresh Vegetables Salads Withdrawal - January 2016
The recalled salads were known to have been distributed to the following states, though there may have been further distribution to other states:
  • Alabama
  • Connecticut
  • Florida
  • Georgia
  • Illinois
  • Indiana
  • Kentucky
  • Louisiana
  • Michigan
  • Massachusetts
  • Maryland
  • Minnesota
  • Missouri
  • Mississippi
  • North Carolina
  • New Jersey
  • New York
  • Ohio
  • Pennsylvania
  • South Carolina
  • Tennessee
  • Virginia
  • Vermont
  • Wisconsin

What are the Symptoms of Listeriosis?

Listeriosis is a rare but serious illness usually caused by eating food contaminated with the bacteria called Listeria. Anyone who experiences fever and muscle aches, sometimes preceded by diarrhea or other gastrointestinal symptoms, or develops fever and chills while pregnant after eating any of the recalled products, should seek medical care and tell the health care provider about eating the potentially contaminated leafy greens. Symptoms can appear from a few days up to a few weeks after eating the contaminated food.

Who is at Risk of Developing Listeriosis? 

Listeriosis can be fatal, especially in certain high-risk groups. These groups include the elderly, and people with weakened immune systems and certain chronic medical conditions (such as cancer). In pregnant women, listeriosis can cause miscarriage, stillbirth, premature labor, and serious illness or death in newborn babies.

What Do Restaurants and Retailers Need to Do to Prevent Listeriosis?

Retailers and restaurants should not serve recalled products and should dispose of them.
They should also:
Wash and sanitize refrigerators where potentially contaminated products were stored.
Wash and sanitize cutting boards, surfaces, and utensils used to cut, serve, or store potentially contaminated products.
Wash hands with warm water and soap following the cleaning and sanitation process.
Retailers, restaurants, and other food service operators who have processed and packaged any potentially contaminated products need to be concerned about cross contamination of cutting surfaces and utensils through contact with these products.
Regular frequent cleaning and sanitizing of cutting boards and utensils used in processing may help to minimize the likelihood of cross-contamination.
Listeria can grow at refrigeration temperatures in foods like leafy greens. Listeria can also cross contaminate other food cut and served on the same cutting board or stored in the same area.
Retailers, restaurants, and other food service operators may wish to consider whether other foods available for sale could be cross-contaminated from the potentially contaminated products, and should be discarded. 

What Can Consumers Do to Prevent Listeriosis?

Recommendations for preventing listeriosis are available at the CDC Listeria website.
Listeria can grow at refrigerator temperatures, about 40 degrees Fahrenheit (4 degrees Celsius). The longer that ready-to-eat refrigerated foods are stored in the refrigerator, the more opportunity Listeria has to grow.
It is very important that consumers thoroughly clean their refrigerators and other food preparation surfaces that may have come in contact with the potentially contaminated products.
Consumers should follow these simple steps:
  • Wash hands with warm water and soap for at least 20 seconds before and after handling food.
  • Wash the inside walls and shelves of the refrigerator, cutting boards and countertops; then sanitize them with a solution of one tablespoon of chlorine bleach to one gallon of hot water; then dry with a clean cloth or paper towel that has not been previously used.
  • Wipe up spills in the refrigerator immediately and clean the refrigerator regularly.
  • Always wash hands with warm water and soap following the cleaning and sanitization process. 

Who Should be Contacted? 

Retailer and consumer questions about the recall should be directed to the Dole Food Company Consumer Response Center at 844-483-3865. Its temporary extended hours are 8:00 a.m. - 8:00 p.m. EST, Monday - Friday.
The FDA also encourages consumers with questions about food safety to call 1-888-SAFEFOOD Monday through Friday between 10 a.m. and 4 p.m. Eastern time, or to consult the fda.gov website: http://www.fda.gov. 

Additional Information



CDC estimates 1 in 68 school-aged children have autism; no change from previous estimate | CDC Online Newsroom | CDC

CDC estimates 1 in 68 school-aged children have autism; no change from previous estimate | CDC Online Newsroom | CDC



CDC. Centers for Disease Control and Prevention. CDC 24/7: Saving Lives. Protecting People.



CDC estimates 1 in 68 school-aged children have autism; no change from previous estimate

Too soon to say whether autism prevalence stabilizing


Press Release

Embargoed Until: Thursday, March 31, 2016, 1:00 p.m. ET
Contact: Media Relations
(404) 639-3286
An estimated 1 in 68 (14.6 per 1,000) school-aged children have been identified with autism spectrum disorder (ASD), according to a CDC report published today in the Morbidity and Mortality Weekly Report (MMWR) Surveillance Summary. This report shows essentially no change in ASD prevalence, the proportion of school aged-children with ASD, from the previous report released in 2014. However, it is too soon to know whether ASD prevalence in the United States might be starting to stabilize. CDC will continue tracking ASD prevalence to better understand changes over time.
The data come from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) Network – a tracking system that provides estimates of the prevalence and characteristics of ASD among 8-year-old children in 11 communities within Arizona, Arkansas, Colorado, Georgia, Maryland, Missouri, New Jersey, North Carolina, South Carolina, Utah, and Wisconsin. The data in the latest report are for 2012 while the data in the previous 2014 report were from 2010.
Although the average ASD prevalence of the 11 ADDM Network sites combined did not change between 2010 and 2012, ASD prevalence still varied widely between the 11 communities. Differences were seen by geographic region and between sites with different access to data resources.
“What we know for sure is that there are many children living with autism who need services and support, now and as they grow into adolescence and adulthood,” said Stuart K. Shapira, MD, PhD, chief medical officer for CDC’s National Center on Birth Defects and Developmental Disabilities.
The new report also underscores where efforts and resources can be directed to better support children and families with ASD. Black and Hispanic children continue to be less likely to be identified with ASD than white children. In addition, black and Hispanic children receive developmental evaluations later than white children.
“Targeted strategies are needed to identify and address barriers in order to lower the age at which black and Hispanic children are evaluated, diagnosed, and connected to the services they need,” said Daisy Christensen, PhD, a CDC epidemiologist and lead author of the ADDM Network report.
The report also shows that, overall, less than half (43%) of children identified with ASD receive developmental evaluations by age 3. This suggests that many children may not be getting identified as early as they could be. Progress needs to be made to reach the Healthy People 2020 goal of increasing to 47% the proportion of children with ASD having a first evaluation by age 3.
“The most powerful tool we have right now to make a difference in the lives of children with ASD is early identification,” said Dr. Shapira. “Parents, childcare professionals and doctors can monitor each child’s development and act right away on any developmental concerns. It’s important to remember that children can be connected to services even before an official diagnosis is made.”
CDC’s “Learn the Signs. Act Early” program provides parents, childcare professionals, and healthcare providers free resources, in English and Spanish, for monitoring children’s development. The program offers parent-friendly, research-based milestone checklists for children as young as 2 months of age. The program also offers information about what to do if there is a developmental concern and whom to contact for assistance.
For more information about “Learn the Signs. Act Early.” visit www.cdc.gov/ActEarly. For more information about CDC’s autism activities, visitwww.cdc.gov/Autism.

REMINDER: 2015 CDC STD Treatment Guidelines Update Webinar in Spanish Tues, Apr 5

REMINDER: 2015 CDC STD Treatment Guidelines Update Webinar in Spanish Tues, Apr 5

HHS, CDC, NCHHSTP, Division of STD Prevention

2015 CDC STD Treatment Guidelines Update Webinar in Spanish
April 5, 2016
1-2 PM EDT
Please join us for this webinar on the 2015 CDC STD Treatment Guidelines, provided in Spanish and hosted by the NYC STD/HIV Prevention Training Center, the University of Washington STD Prevention Training Center, the National Network of STD Clinical Prevention Training Centers, and the Centers for Disease Control and Prevention.
The STD Treatment Guidelines were developed through a rigorous peer-review process to assist clinicians and healthcare providers in giving their patients the appropriate STD testing, treatment, and counseling messages. The CDC released the 2015 STD Treatment Guidelines in June 2015, and included updated testing, treatment, and diagnosis recommendations.
Target Audience: Clinical providers; Physicians, nurses, advanced practice nurses, and Physicians’ Assistants.
Continuing medical and nursing education credits (CME/CNE) are available.
***
MÉDICOS, ENFERMERAS Y PERSONAL CLÍNICO PARTICIPA
 Seminario por la internet (webinar) Actualización de las Guías de Tratamiento de Enfermedades Transmisibles Sexualmente (ETS) 2015 del CDC

Este seminario será ofrecido por el NYC STD/HIV Prevention Training Center y University of Washington National STD Curriculum Center.

Día: Martes, 5 de abril de 2016 Hora: 1-2 PM EDT
Costo: GRATIS
Educación Continua: SI (CME/CNE)
Registro en: 2015 CDC STD Treatment Guidelines en Español

The latest news and updates from BioMed Central


BioMed Central ? The Open Access Publisher
Featured news and updates
Pneumonia journal moves to BioMed Central
Pneumonia has opened for submissions at BioMed Central following an agreement in December to transfer the title from Griffith University ePress, Australia.
Pneumonia is an international, peer reviewed open access journal that publishes original research articles, case studies, reviews, commentaries, correspondence and highlights, news and activities on all aspects related to pneumonia. It is the only journal that is focused exclusively on the subject. There are no processing charges for manuscripts published in pneumonia and published articles are freely available online.

Congratulations to Associate Professor Bruce Walker who has been awarded Membership in the General Division of the Order of Australia (AM) in the Australia Day honors. Associate Professor Walker said he was very proud of the award and that it was a tribute to the chiropractic profession at large and in particular to those evidence based chiropractors who have fearlessly pursued science and guided the profession in the right direction. He said the award was the result of a team effort and belongs to all the very motivated and talented teams of people who supported him throughout his career.


BioMed Central in the news
The alcohol harm paradox explained
Research published in BMC Public Health looked at people who drank in excess, defined as 6 pints of beer per week for women and 9 pints for men. The researchers found that despite drinking the same amounts of alcohol, people in deprived communities have higher levels of alcohol-related ill health than people in wealthier communities.

People who are heavier drinkers and live in low-income communities were nearly 11 times more likely to combine drinking with smoking, excess weight, poor diet and little exercise than people living in non-deprived areas. These combinations not only add to the dangers from alcohol consumption but effectively multiply the risks of ill health.

This was popular with the mainstream and medical press, and was covered in the UK and US by outlets including The Times; Daily Mail; Medical Daily andSTAT. It was also covered by The Australian and SBSin Australia; and The Statesman and The Times of Indiain India.

Science careers are careers that involve science
February marked the start of a new blog series looking at the wide array of scientific careers out there. Dana Berry aims to provide a source of information for those interested in science, and the career options.

What your gut bacteria can tell you about type 2 diabetes
Bacteria found in faecal matter can predict your risk for diabetes, according to research published in Genome Medicine. Identifying variations in the types and activities of microorganisms that live in the human gut could help early diagnosis of type 2 diabetes. The researchers looked at identical twins aged 30 to 48 years and showed that changes in the gut microbiota are already present at sub-clinical and pre-onset stages of type 2 diabetes.

This press release gained international coverage in relevant health outlets as well as the mainstream press. It was reported by Medical News Today and Medical XPress in the UK; US News & World Report and STATin US; SBS in Australia; Interbusca and infosalus.com in Spain; as well as by MedSci in China.

All about cancer: World Cancer Day 2016
February 4 marked World Cancer Day and this year the theme was 'We Can. I Can.' encouraging individuals to engage in specific actions to fight the disease. In light of this, BMC Medicine highlighted some of their recent publications looking at the latest advances in cancer research, helping us to move closer to the success of fighting cancer.


Open Access Landscape Update
Report by Professor Adam Tickell advocates open access in the UK
As of March 2016 we have identified 85 APC funds provided by funding bodies, and 125 institutional APC funds that are funded in whole or in part by the institution, with a further 172 institutions that solely distribute OA block funds from research funders or from a consortium fund.

Professor Adam Tickell, Provost and Vice Principal at the University of Birmingham has released an independent report for the UK government on open access policy at a national level. Tickell promotes a gold open access approach across the UK, as reflected in RCUK funding as well as policies across agencies and institutions. This is the same model which has been used by BioMed Central since 2005.The report gives recommendations for the UUK OA Coordination Group (for which Tickell is Chair) and has received a positive response from the Minister of State for Universities and Science, Jo Johnson, and from our parent company, Springer Nature.

Elizabeth Moylan appointed to Committee on Publication Ethics Council
Elizabeth Moylan, Senior Editor (Research Integrity) at BioMed Central has been appointed to the Committee on Publication Ethics (COPE) Council. The COPE Council are responsible for the operational activities of COPE and are Constitutional Members of COPE under company law.

Elizabeth originally joined BioMed Central in 2004, as an in-house Editor handling peer review on the BMC series of journals in the early days of the open access movement. In subsequent roles she has been involved in journal development activity across a number of BMCseries titles including overseeing the launch of various journals. In her present role she has oversight of editorial policies and peer review processes and is particularly interested in new models of peer review.


BioMed Central on the Road
San Diego, USA, 04.02.2016

Kyoto, Japan, 04.03.2016

Leipzig, Germany, 04.06.2016

Baltimore, USA, 04.14.2016

New Orleans, USA, 04.16.2016


Best wishes,

The BMC Update Team
BioMed Central Register

Improving Access to Treatment: Expanding reach of Buprenorphine

Dept. of Health & Human Services
March 31, 2016
By: Kana Enomoto, Principle Deputy Administrator, Substance Abuse and Mental Health Services Administration and Richard Frank, Assistant Secretary for Planning and Evaluation at HHS
The opioid problem won’t wait.  Seventy-eight people die every day in the United States from an opioid overdose.  Nearly 2.2 million Americans struggle every day with an addiction to opioid pain medications or illegal opioids like heroin.  Opioid addiction, also called opioid use disorder, is a complex disease associated with chronic drug use, high-risk behavior, and a host of other medical and behavioral complications.
Recovery is possible. The good news is that we have treatments that we know are effective, using a combination of medication, counseling and other supports – known as medication assisted treatment (MAT).  The more disappointing news is that more than half the people who could use treatment are not able to get it, in large part because they can’t afford it or can’t find providers.  We can do better and we must.
The Department of Health and Human Services is taking bold steps to improve access to treatment, especially to MAT with buprenorphine, methadone and naltrexone.  The federal government cannot address all the barriers to treatment, but we will take action where we can to make it easier for people to get the treatment that can turn their lives around – and often times save their lives.
The proposed regulation we issued this week seeks to ease one of these barriers - the limit on the number of patients a physician can treat with buprenorphine at a given time.  Right now physicians can only treat up to 100 patients at a time with buprenorphine.  While this limit has increased over time (the Drug Addiction and Treatment Act of 2000, DATA 2000, limited physicians to 30 patients), one might wonder why there is a limit at all. We have heard from physicians, addiction specialists and others that the caseload limit of 100 is too low and can mean that some people who need treatment do not get it.
READ MORE: Improving Access to Treatment: Expanding reach of Buprenorphine

CDC MMWR News Synopsis for March 31, 2016

MMWR- Morbidity and Mortality Weekly Report
MMWR News Synopsis for March 31, 2016

Campylobacter jejuni Infections Associated with Raw Milk Consumption – Utah, 2014

Consumers should be aware of dangers associated with consuming unpasteurized milk. An estimated 3% of the U.S. population drinks raw milk, and prefers it to pasteurized milk, in part because of perceived health benefits of raw milk consumption. Raw milk can be contaminated with Campylobacter in different ways. Documented outbreaks in which human cases of Campylobacter infection have been linked by PFGE to raw milk are rare. This article reports findings of an investigation linking consumers of raw milk to C. jejuni infection through PFGE. Routine testing of and standards for raw milk (somatic cell and coliform counts) do not ensure that the raw milk is free of pathogens. Current raw milk testing standards do not readily detect contamination; thus, the safest alternative is to consume pasteurized milk.

Retail Deli Slicer Cleaning Frequency – Six Selected Sites, United States, 2012

CDC recommend that states, localities, and the retail food industry use information from this study to inform prevention efforts. These efforts should focus on independent and small delis and should encourage or require deli manager training and certification and written slicer-cleaning policies consistent with FDA guidelines. Listeria monocytogenes (Listeria) causes the third highest number of foodborne illness deaths in the United States each year. It has been found in a variety of foods, including cooked or processed foods such as deli meats. Listeria contamination of sliced deli meats at retail locations is a major cause of Lm illness and outbreaks. To prevent this, the Food and Drug Administration (FDA) Food Code recommends that food contact surfaces, like deli slicers, be fully cleaned (taken apart, cleaned, and sanitized) at least every 4 hours. About half of the sampled retail delis did not fully clean their slicers as often as FDA recommends. FDA sets these recommendations to prevent Listeria and other germs from spreading.


Notes from the Field:
  • Imported Cases of Malaria – Puerto Rico, July-October 2015
  • Baseline Assessment of the Use of Ebola Rapid Diagnostic Tests – Forécariah, Guinea, October 2015-November 2015


QuickStats:
  • Death Rates for Children and Adolescents Aged 1–14 Years, by Sex — United States, 1999–2014

New CDC Resource - Infection Prevention in Dental Settings: Basic Expectations for Safe Care

Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care



New CDC Resource - Infection Prevention in Dental Settings: Basic Expectations for Safe Care



Guidelines for Infection Control in Dental Health-Care Settings

This week, the Centers for Disease Control and Prevention released a resource to help dental health care personnel prevent causing and spreading infections among their patients. The comprehensive but user-friendly document, “Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care,” features several new tools to help personnel understand and follow infection prevention guidelines. For example, the Infection Prevention Checklist (Appendix A, page 20) can be used to assess a dental setting’s infection prevention policies and practices and personnel compliance with infection prevention practices.  
For more information, please visit the CDC’s Division of Oral Health website. For more information on injection safety, visit the One & Only Campaign website.